Cargando…

Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study

Eplets are defined as distinct amino acid configurations on the surface of HLA molecules. The aim of this study was to estimate the immunogenicity of HLA‐DQ eplets in a cohort of 221 pregnancies with HLA‐DQ mismatches. We defined the immunogenicity of an eplet by the frequency of antibody responses...

Descripción completa

Detalles Bibliográficos
Autores principales: Schawalder, Lara, Hönger, Gideon, Kleiser, Marc, van Heck, Michelle R., van de Pasch, Loes A. L., Vendelbosch, Sanne, Rozemuller, Erik H., Schaub, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756751/
https://www.ncbi.nlm.nih.gov/pubmed/33068062
http://dx.doi.org/10.1111/tan.14110
_version_ 1783626609890164736
author Schawalder, Lara
Hönger, Gideon
Kleiser, Marc
van Heck, Michelle R.
van de Pasch, Loes A. L.
Vendelbosch, Sanne
Rozemuller, Erik H.
Schaub, Stefan
author_facet Schawalder, Lara
Hönger, Gideon
Kleiser, Marc
van Heck, Michelle R.
van de Pasch, Loes A. L.
Vendelbosch, Sanne
Rozemuller, Erik H.
Schaub, Stefan
author_sort Schawalder, Lara
collection PubMed
description Eplets are defined as distinct amino acid configurations on the surface of HLA molecules. The aim of this study was to estimate the immunogenicity of HLA‐DQ eplets in a cohort of 221 pregnancies with HLA‐DQ mismatches. We defined the immunogenicity of an eplet by the frequency of antibody responses against it. Around 90% of all listed DQB1 or DQA1 eplets were at least five times mismatched and thus included for the calculation of their immunogenicity. The DQB1 eplets with the five highest immunogenicity scores were 55PP, 52PR, 52PQ, 85VG and 45EV; 25% of all DQB1 eplets were not reacting. The DQA1 eplets with the five highest immunogenicity scores were 25YS, 47QL, 55RR, 187T and 18S; 17% of all DQA1 eplets were not reacting. The immunogenicity score had a slightly higher area under the curve to predict development of child‐specific antibodies than various molecular mismatch scores (eg, eplet mismatch load, amino acid mismatch load). Overlapping eplets were identified as a barrier to unambiguously assign the immunogenicity score based on HLA antibody reaction patterns. In this conceptual study, we explored the immunogenicity of HLA‐DQ eplets and created a map of potentially immunogenic regions on HLA‐DQ molecules, which requires validation in clinical transplant cohorts.
format Online
Article
Text
id pubmed-7756751
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-77567512020-12-28 Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study Schawalder, Lara Hönger, Gideon Kleiser, Marc van Heck, Michelle R. van de Pasch, Loes A. L. Vendelbosch, Sanne Rozemuller, Erik H. Schaub, Stefan HLA Original Articles Eplets are defined as distinct amino acid configurations on the surface of HLA molecules. The aim of this study was to estimate the immunogenicity of HLA‐DQ eplets in a cohort of 221 pregnancies with HLA‐DQ mismatches. We defined the immunogenicity of an eplet by the frequency of antibody responses against it. Around 90% of all listed DQB1 or DQA1 eplets were at least five times mismatched and thus included for the calculation of their immunogenicity. The DQB1 eplets with the five highest immunogenicity scores were 55PP, 52PR, 52PQ, 85VG and 45EV; 25% of all DQB1 eplets were not reacting. The DQA1 eplets with the five highest immunogenicity scores were 25YS, 47QL, 55RR, 187T and 18S; 17% of all DQA1 eplets were not reacting. The immunogenicity score had a slightly higher area under the curve to predict development of child‐specific antibodies than various molecular mismatch scores (eg, eplet mismatch load, amino acid mismatch load). Overlapping eplets were identified as a barrier to unambiguously assign the immunogenicity score based on HLA antibody reaction patterns. In this conceptual study, we explored the immunogenicity of HLA‐DQ eplets and created a map of potentially immunogenic regions on HLA‐DQ molecules, which requires validation in clinical transplant cohorts. Blackwell Publishing Ltd 2020-10-28 2021-01 /pmc/articles/PMC7756751/ /pubmed/33068062 http://dx.doi.org/10.1111/tan.14110 Text en © 2020 The Authors. HLA: Immune Response Genetics published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Schawalder, Lara
Hönger, Gideon
Kleiser, Marc
van Heck, Michelle R.
van de Pasch, Loes A. L.
Vendelbosch, Sanne
Rozemuller, Erik H.
Schaub, Stefan
Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study
title Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study
title_full Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study
title_fullStr Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study
title_full_unstemmed Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study
title_short Development of an immunogenicity score for HLA‐DQ eplets: A conceptual study
title_sort development of an immunogenicity score for hla‐dq eplets: a conceptual study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756751/
https://www.ncbi.nlm.nih.gov/pubmed/33068062
http://dx.doi.org/10.1111/tan.14110
work_keys_str_mv AT schawalderlara developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy
AT hongergideon developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy
AT kleisermarc developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy
AT vanheckmicheller developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy
AT vandepaschloesal developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy
AT vendelboschsanne developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy
AT rozemullererikh developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy
AT schaubstefan developmentofanimmunogenicityscoreforhladqepletsaconceptualstudy